Sandip Dhondiram Gurav
Sandip Dhondiram Gurav publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as Pesticide Residue Analysis and Safety, Cancer therapeutics and mechanisms and Antibiotics Pharmacokinetics and Efficacy.
- World rank
- #6,410,742 of 7,710,434 ranked researchers
- Rank in India
- #208,092 of 280,097
- Works
- 15
- Citations
- 98
- Citations per work
- 6.5
What does Sandip Dhondiram Gurav research?
Sandip Dhondiram Gurav's work is mostly in Biochemistry, Genetics and Molecular Biology (23%), Medicine (19%), Agricultural and Biological Sciences (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else744.1%
- Life Sciences637.3%
- Health Sciences318.6%
- Medicine318.6%
- 1Molecular Biology16% of their works
- 2Oncology12% of their works
- 3Cancer Research7% of their works
- 4Pharmacology7% of their works
- 5Food Science7% of their works
- 6Pharmacology7% of their works
Research topics
- Pesticide Residue Analysis and Safety
- Cancer therapeutics and mechanisms
- Antibiotics Pharmacokinetics and Efficacy
- Estrogen and related hormone effects
- Pharmacogenetics and Drug Metabolism
- Analytical Methods in Pharmaceuticals
- Drug Transport and Resistance Mechanisms
- Colorectal Cancer Treatments and Studies
Which keywords describe Sandip Dhondiram Gurav's research?
The keywords of their largest research topics: Chemotherapy, Method Validation, Nuclear Receptors, Antibiotic Pharmacokinetics, Critically Ill Patients, DNA, Liquid Chromatography and Pesticide Residues.
- Pharmacogenetics
- Multidrug Resistance
- Green Analytical Chemistry
- Cytochrome P450
- ATP-dependent Transporters
- Pesticide Residues
- DNA
- Antibiotic Pharmacokinetics
- Method Validation
- Chemotherapy
- Nuclear Receptors
- Critically Ill Patients
- Liquid Chromatography
- Topoisomerases
- Cetuximab
- Estrogen
- KRAS Mutations
- Pharmaceutical Analysis
- Receptor
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Chemotherapy52 topics
- Method Validation52 topics
- Nuclear Receptors42 topics
- Antibiotic Pharmacokinetics31 topic
- Critically Ill Patients31 topic
- DNA31 topic
- Liquid Chromatography31 topic
- Pesticide Residues31 topic
- Topoisomerases31 topic
- ATP-dependent Transporters21 topic
- Cetuximab21 topic
- Cytochrome P45021 topic
- Estrogen21 topic
- Green Analytical Chemistry21 topic
- KRAS Mutations21 topic
- Multidrug Resistance21 topic
- Pharmaceutical Analysis21 topic
- Pharmacogenetics21 topic
- Receptor21 topic
Where does Sandip Dhondiram Gurav work?
Sandip Dhondiram Gurav's main affiliation in the publication record is Jubilant Life Sciences (India), India.
How many publications and citations does Sandip Dhondiram Gurav have?
OpenAlex counts 15 works and 98 citations for Sandip Dhondiram Gurav, an h-index of 4, ranking #6,410,742 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sandip Dhondiram Gurav. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.